Daniel R. Chard - 22 Feb 2022 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Chairman & CEO, Director
Signature
/s/ Jason L. Groves, attorney-in-fact
Issuer symbol
MED
Transactions as of
22 Feb 2022
Net transactions value
-$546,407
Form type
4
Filing time
24 Feb 2022, 20:06:19 UTC
Previous filing
21 Apr 2022
Next filing
21 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Tax liability $319,416 -1,804 -11% $177.06 13,912 22 Feb 2022 Direct F1, F2
transaction MED Common Stock Tax liability $226,991 -1,282 -9.2% $177.06 12,630 22 Feb 2022 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares vested on February 19, 2022, which fell on a weekend. The settlement date of this vesting and subsequent withholding fell on the following business day, February 22, 2022.
F2 Pursuant to the terms of the Issuer's Amended and Restated 2012 Share Incentive Plan, the price was the closing sales price for the most recent trading day prior to the vesting date.
F3 These shares vested on February 20, 2022, which fell on a weekend. The settlement date of this vesting and subsequent withholding fell on the following business day, February 22, 2022.